White label ELPA - ClinicalTrials.eu

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Not recruiting

2 1
Investigated Drugs:
- Azd3427
+3
Study on the Effects of Modified-Release Hydrocortisone vs. Immediate-Release Hydrocortisone for Patients with Addison’s Disease

Not recruiting

2 1 1 1
Investigated Diseases:
- Addison’s disease
Investigated Drugs:
- Hydrocortisone
Study on Efzofitimod for Treating Pulmonary Sarcoidosis in Patients

Not recruiting

3 1 1
Investigated Diseases:
- Pulmonary sarcoidosis
Investigated Drugs:
- Efzofitimod
Study on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7

Not recruiting

3 1 1
Investigated Drugs:
Study of Risankizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

Not recruiting

3 1 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Risankizumab
- Ustekinumab
Study on GSK3858279 for Adults with Moderate to Severe Knee Osteoarthritis Pain

Not recruiting

2 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
- Gsk3858279
Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
+1
Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Not recruiting

3 1 1 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
- Tenecteplase
Study on the Safety of DS-2325a for Patients with Netherton Syndrome

Not recruiting

1 1 1
Investigated Diseases:
- Netherton’s syndrome
Investigated Drugs:
- Ds-2325A
- Sodium Chloride Solution 0.9%
Study Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Lung adenocarcinoma
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies